Examining decentralization and managerial decision making for child immunization program performance in India.
Feldhaus I, Chatterjee S, Clarke-Deelder E, Brenzel L, Resch S, Bossert TJ.
Soc Sci Med. 2023 01. 317:115457. PMID: 36493499
Lecturer on Health Decision Science
Health Policy and Management
Harvard T.H. Chan School of Public Health
Stephen Resch, MPH, PhD, is a Lecturer on Health Decision Science in the Department of Health Policy and Management at the Harvard T.H. Chan School of Public Health. He is a core faculty member of the Center for Health Decision Science.
Dr. Resch's research focuses on advancing the use of decision analytic approaches in health policymaking and health program management. As a generalist with a passion for practical applications of technical analysis to aid decision-making, he often works closely with global health organizations and government officials across a broad range of public health topics and settings. Internationally, his work has addressed policy issues related to resource requirements, financial sustainability, and economic efficiency of health programs to treat or prevent of HIV, TB, malaria, and hepatitis, as well as programs to improve maternal and neonatal survival in childbirth, and vaccination. Domestically, he has worked on evaluation of obesity prevention interventions, HIV testing and linkage to care for incarcerated populations, and evaluation of dental interventions to prevent tooth decay in high-risk children.
Dr. Resch's work often involves constructing decision analytic models and employing computer simulation to predict health benefits, costs and other social impacts of alternative policy options. His core motivation is to aid decision makers in identifying decision criteria consistent with their goals and providing evidence that clarifies relevant constraints, trade-offs and uncertainties. He holds and MPH from Yale University and a PhD from Harvard University. He teaches a course on economic evaluation in the decision science curriculum at the Harvard Chan School.
PhD, 03/2007, Health Policy
Harvard University, Cambridge, MA
BS, 05/1996, Molecular Cell Biology
University of Connecticut, Storrs, CT
MPH, 05/2001, Health Policy
Yale School of Public Health, New Haven, CT
Feldhaus I, Chatterjee S, Clarke-Deelder E, Brenzel L, Resch S, Bossert TJ.
Soc Sci Med. 2023 01. 317:115457. PMID: 36493499
Resch SC, Suarez S, Omotayo MO, Griffin J, Sessler D, Burke T.
BMJ Open. 2022 10 05. 12(10):e051055. PMID: 36198454
Resch SC, Foote JHA, Wirth KE, Lasry A, Scott JA, Moore J, Shebl FM, Gaolathe T, Feser MK, Lebelonyane R, Hyle EP, Mmalane MO, Bachanas P, Yu L, Makhema JM, Holme MP, Essex M, Alwano MG, Lockman S, Freedberg KA.
J Acquir Immune Defic Syndr. 2022 08 01. 90(4):399-407. PMID: 35420554
Levin A, Boonstoppel L, Brenzel L, Griffiths U, Hutubessy R, Jit M, Mogasale V, Pallas S, Resch S, Suharlim C, Yeung KHT.
BMC Med. 2022 03 08. 20(1):88. PMID: 35255920
Lofgren KT, Bobanski L, Tuller DE, Singh VP, Marx Delaney M, Jurczak A, Ragavan M, Kalita T, Karlage A, Resch SC, Semrau KEA.
BMJ Open. 2022 Feb 07. 12(2):e054164. PMID: 35131826
Nonvignon J, Owusu R, Asare B, Adjagba A, Aun YW, Yeung KHT, Azeez JNK, Gyansa-Lutterodt M, Gulbi G, Amponsa-Achiano K, Dadzie F, Armah GE, Brenzel L, Hutubessy R, Resch SC.
Vaccine. 2022 03 15. 40(12):1879-1887. PMID: 35190206
Sato R, Daures M, Phelan K, Shepherd S, Kinda M, Becquet R, Hecht R, Resch S.
Matern Child Nutr. 2022 04. 18(2):e13291. PMID: 34957682
Murphy JP, Kgowedi S, Naidoo N, Girdwood S, Jamieson L, Soeteman D, Resch S, Meyer-Rath G.
Health Policy Plan. 2021 Nov 11. 36(10):1545-1551. PMID: 34212192
Neilan AM, Bulteel AJB, Hosek SG, Foote JHA, Freedberg KA, Landovitz RJ, Walensky RP, Resch SC, Kazemian P, Paltiel AD, Weinstein MC, Wilson CM, Ciaranello AL.
Clin Infect Dis. 2021 10 05. 73(7):e1927-e1935. PMID: 32730625
Chatterjee S, Das P, Pinheiro A, Haldar P, Ray A, Brenzel L, Resch S.
Health Policy Plan. 2021 Sep 09. 36(8):1316-1324. PMID: 33950262
June 8, 2018 – A new online catalogue that provides information on the costs of delivering immunizations in 31 countries is aimed at helping decision-makers, particularly in low- and middle-income countries, better understand the long-term costs of running…
A study analyzing the cost structure of routine immunization programs in six countries found that the most efficient programs had the lowest labor costs. The study from Harvard T.H. Chan School of Public Health, published in the journal…
July 21, 2016 -- As new vaccines are introduced—some of them quite costly—accurate information on the cost and financing of national immunization programs can be lacking. Research and a new website developed at Harvard T.H. Chan School of…
The Centers for Disease Control and Prevention (CDC) may have underestimated the number of obese adults in the U.S. in its 2013 Obesity Prevalence Maps by at least 12 million because of reliance upon self-reported height and weight…
As economies improve in sub-Saharan Africa, the region’s 12 countries could cover more of the funding for HIV/AIDS programs, according to a new analysis by Harvard T.H. Chan School of Public Health lecturer Stephen Resch and colleagues at…